Testing of Carryover & After MRD Benchtop Stability for Pharmacokinetic Method Validation in Gyrolab Immunoassay Platform

In this white paper, we show testing of two critical parameters for the method validation of Gyrolab: 1) carryover contamination and 2) after MRD (minimum required dilution) stability.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

This field is for validation purposes and should be left unchanged.

Testing of Carryover & After MRD Benchtop Stability for Pharmacokinetic Method Validation in Gyrolab Immunoassay Platform

Resources to Consider

Stability Study for EMLA Cream Using In Vitro Percutaneous Absorption

Overcoming Stability Issues in the Development of an LC-MS/MS...

Stability Testing

CMC Stability Testing As A Quality Control Measure

Neurofilament Light Chain: Method Validation of Quantitation Using...

Method Validation of Quantitation IL-17A in Human Serum using the...

Development and validation of an LC-MS/MS method for the...

Bioanalytical Methods for Emerging Therapies

Development and Validation of an LC-MS.MS Method for the Simultaneous...

An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous...

Development And Validation Of LC-MS/MS Methods For The…

Development and Validation of an Ultra Sensitive LC-MS/MS Method for...